See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2024_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,528,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,500,000 |
| 2 | PropertyPlantAndEquipmentNet | 540,000 |
| 3 | remainder_Assets | 4,011,000 |
| 4 | LiabilitiesCurrent | 25,018,000 |
| 5 | LiabilitiesNoncurrent | 15,978,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 12,982 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,380,229 |
| 9 | ResearchAndDevelopmentExpense | 25,881,036 |
| 10 | remainder_Expenses | -2,018,210 |
| 11 | remainder_Revenues | 111,691 |
| 12 | remainder_NetIncome | -8,874,275 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,579,000 |
| 1 | Liabilities | 40,996,000 |
| 2 | Expenses | 35,256,037 |
| 3 | Revenues | 111,691 |
| 4 | StockholdersEquity | -24,417,000 |
| 5 | NetIncome | -44,018,621 |
| 6 | ComprehensiveNetIncome | -44,018,621 |
| 7 | BaseVar | 50,908,502 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.38 |
| 9 | EconomicCapitalRatio | 0.566 |
Edgar->Model Mapping
Feature Distribution
Change over Time
